Safety and Pharmacokinetic Characteristics of DKF-313

Clinical trial NCT02352311 · COMPLETED

Trial details

NCT number: NCT02352311
Sponsor: Dongkook Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Benign Prostate Hyperplasia Healthy

Start date: 2015-01-01
Primary completion: 2015-06-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.